Literature DB >> 11828186

Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III.

N D Wong1, J Pio, R Valencia, G Thakal.   

Abstract

The authors examined the distribution of, and risk factors associated with, the inflammatory marker C-reactive protein (CRP) among a large sample of non-institutionalized American adults aged 30-74 years of age, and its relation to estimated 10-year coronary heart disease risk. The population studied comprised 4472 men and 5212 women aged 30-74 years, without coronary heart disease, who had CRP measurements in the Third National Health and Nutrition Examination Survey (NHANES III). The 10-year risk of coronary heart disease was estimated from Framingham risk factor algorithms among those with CRP levels of less-than-or-equal0.21 mg/dL, >0.21 to <0.5mg/dL, 0.5 to <1.0 mg/dL, and greater-than-or-equal1.0 mg/dL. Mean (SD) levels of CRP were 0.41 (0.64) mg/dL in men and 0.55 (0.91) mg/dL in women. Levels of at least 1 mg/dL were measured in 6.4% of men and 12.9% of women. CRP levels were highest among non-Hispanic black men and Mexican-American women. According to multiple logistic regression analysis, cigarette smoking and increased age, body mass index, and systolic blood pressure in men, and body mass index and diabetes in women, were strongly associated with a greater likelihood of CRP levels of greater-than-or-equal1.0 mg/dL (p<0.001). Among persons with CRP levels of less-than-or-equal0.21 mg/dL, >0.21 to <0.5 mg/dL, 0.5 to <1.0 mg/dL and greater-than-or-equal1.0 mg/dL, the 10-year estimated risk of coronary heart disease were 13.4%, 17.6%, 19.6%, and 21.1% among men, respectively, and 2.7%, 3.6%, 4.1% and 4.3% among women, respectively (both p<0.001 across CRP categories); higher risks across CRP groups were also found among ethnic/gender subgroups. CRP remained a significant predictor of coronary heart disease risk in unadjusted and age-adjusted analyses. Conclusion. Elevation of CRP is associated with several major coronary heart disease risk factors and with unadjusted and age-adjusted projections of 10-year coronary heart disease risk in both men and women. (c)2001 CHF, Inc. Presented at the Fifth International Conference on Preventive Cardiology, Osaka, Japan, May, 2001.

Entities:  

Year:  2001        PMID: 11828186     DOI: 10.1111/j.1520-037x.2001.00570.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  30 in total

1.  Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.

Authors:  C Noel Bairey Merz; Saralyn Mark; Barbara D Boyan; Alice K Jacobs; Prediman K Shah; Leslee J Shaw; Doris Taylor; Eduardo Marbán
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

2.  Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).

Authors:  Ervin R Fox; Emelia J Benjamin; Daniel F Sarpong; Charles N Rotimi; James G Wilson; Michael W Steffes; Guanjie Chen; Adebowale Adeyemo; Jason K Taylor; Tandaw E Samdarshi; Herman A Taylor
Journal:  Am J Cardiol       Date:  2008-07-25       Impact factor: 2.778

3.  GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment.

Authors:  Rami A Ballout; Alan T Remaley
Journal:  J Lab Precis Med       Date:  2020-04-20

Review 4.  Myocardial ischemia in women: lessons from the NHLBI WISE study.

Authors:  Martha Gulati; Leslee J Shaw; C Noel Bairey Merz
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

5.  Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.

Authors: 
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

6.  Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations.

Authors:  Isabelle Anne Rossi; Murielle Bochud; Pascal Bovet; Fred Paccaud; Gérard Waeber; Peter Vollenweider; Patrick Taffé
Journal:  Eur J Epidemiol       Date:  2012-03-06       Impact factor: 8.082

Review 7.  Women and ischemic heart disease: evolving knowledge.

Authors:  Leslee J Shaw; Raffaelle Bugiardini; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

8.  Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey.

Authors:  Stephen M Amrock; Michael Weitzman
Journal:  Atherosclerosis       Date:  2014-06-23       Impact factor: 5.162

9.  Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality.

Authors:  Abel Romero-Corral; Virend K Somers; Justo Sierra-Johnson; Yoel Korenfeld; Simona Boarin; Josef Korinek; Michael D Jensen; Gianfranco Parati; Francisco Lopez-Jimenez
Journal:  Eur Heart J       Date:  2009-11-20       Impact factor: 29.983

Review 10.  The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women.

Authors:  LaPrincess C Brewer; Anna Svatikova; Sharon L Mulvagh
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.